approval

Venus drug gets patent approval from Oz and Ukraine

Venus drug gets patent approval from Oz and Ukraine
New Delhi, Oct 18 (PTI) Drug firm Venus Remedies today said Australian and Ukrainian patent authorities have granted patents for its research product Potentox, used in treating pneumonia and febrile neutropenia.
Read more on Press Trust of India

Talecris Biotherapeutics Receives FDA Approval For Gamunex®-C

Talecris Biotherapeutics Receives FDA Approval For Gamunex®-C
Talecris Biotherapeutics (Nasdaq: TLCR) announced that the U.S. Food and Drug Administration (FDA) approved Gamunex®-C (Immune Globulin Injection [Human], 10% Caprylate/Chromatography Purified) for subcutaneous administration in the treatment of primary immunodeficiency (PI). The newly approved Gamunex-C provides both the intravenous route of administration… Continue reading

Alkermes addiction drug wins wider U.S. approval

Alkermes addiction drug wins wider U.S. approval
* Vivitrol already used in U.S. for alcoholics
Read more on Reuters via Yahoo! Singapore News

Toronto sports star doctor indicted
Canadian doctor Anthony Galea was formally indicted on Thursday on charges of smuggling unapproved drugs into the United States to treat high-profile… Continue reading

The Partnership at Drugfree.org Comments on FDA Approval of Alkermes Opioid Dependence Medication

The Partnership at Drugfree.org Comments on FDA Approval of Alkermes Opioid Dependence Medication
Statement of Steve Pasierb, President NEW YORK, Oct. 13 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration’s approval of Alkermes’ opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive… Continue reading

Alkermes Announces FDA Approval of VIVITROL® for Prevention of Relapse to Opioid Dependence

Alkermes Announces FDA Approval of VIVITROL® for Prevention of Relapse to Opioid Dependence
WALTHAM, Mass.–(BUSINESS WIRE)–Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL® for the prevention of relapse to opioid dependence, following opioid detoxification.
Read more on Business Wire

Man charged with DUI… Continue reading

FDA broadens approval of monthly Vivitrol injection to treat opioid addiction

FDA broadens approval of monthly Vivitrol injection to treat opioid addiction
WASHINGTON – Drugmaker Alkermes Inc. said Tuesday it has received U.S. approval to market its addiction medication for use in patients addicted to narcotics like heroin and morphine.
Read more on Minneapolis-St. Paul Star Tribune

Scots policeman ‘raped vulnerable… Continue reading